128 related articles for article (PubMed ID: 27101583)
1. Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
Zhang L; Zhan X; Yan D; Wang Z
Int J Gynecol Cancer; 2016 Jun; 26(5):810-6. PubMed ID: 27101583
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
[TBL] [Abstract][Full Text] [Related]
4. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X
Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
6. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.
Xu D; Liu S; Zhang L; Song L
Biochem Biophys Res Commun; 2017 Apr; 485(2):556-562. PubMed ID: 27923652
[TBL] [Abstract][Full Text] [Related]
7. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
Sun D; Wang C; Long S; Ma Y; Guo Y; Huang Z; Chen X; Zhang C; Chen J; Zhang J
Br J Cancer; 2015 Apr; 112(9):1491-500. PubMed ID: 25867276
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
9. MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
Zhou Q; Han LR; Zhou YX; Li Y
Int J Gynecol Cancer; 2016 Jun; 26(5):817-24. PubMed ID: 27206216
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
12. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
14. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
15. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X
Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
17. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
Zhang X; Cai D; Meng L; Wang B
Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]